ADPT
Adaptive Biotechnologies Corp
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Adaptive Biotechnologies Corp
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+7.18%
vs ±15.2% implied · ×0.47
shaded = implied · ▲▼ = realized
No thesis.
Linked news
Adaptive Biotechnologies Corp
26.62
−1.55 · −5.51%
post 26.60 −0.07%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Viking Global InvestorsViking Global Investors | $643.4M | 18.45% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $324.7M | 9.31% | +13.80% | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $137.4M | 3.94% | +5.08% | |
| 4 | Wellington Management GroupWellington | $126.8M | 3.64% | +53.25% | |
| 5 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $117.5M | 3.37% | +21.93% | |
| 6 | D. E. ShawD. E. Shaw | $99.2M | 2.84% | +135.34% | |
| 7 | Westfield Capital ManagementWestfield | $91.5M | 2.62% | −21.50% | |
| 8 | Geode Capital ManagementGeodeindex-like | $78.1M | 2.24% | +0.16% | |
| 9 | State StreetState Streetindex-like | $74.2M | 2.13% | +7.16% | |
| 10 | UBS GroupUBS | $67.2M | 1.93% | +1285.29% | |
| 11 | InvescoInvesco | $66.4M | 1.90% | new | |
| 12 | Goldman Sachs GroupGoldman Sachs | $64.0M | 1.84% | −7.95% | |
| 13 | T. Rowe Price AssociatesT. Rowe Price | $57.2M | 1.64% | +70.18% | |
| 14 | Driehaus Capital ManagementDriehaus | $54.2M | 1.55% | +44.39% | |
| 15 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $54.2M | 1.55% | +26.53% | |
| 16 | Lord, AbbettLord, Abbett | $53.1M | 1.52% | −30.01% | |
| 17 | NuveenNuveenindex-like | $50.8M | 1.46% | +81.43% | |
| 18 | BNP Paribas Investment PartnersBNP Paribas Investment Partners | $46.8M | 1.34% | −18.81% | |
| 19 | Susquehanna International GroupSusquehanna International | $46.5M | 1.33% | +971.87% | |
| 20 | Fred Alger ManagementFred Alger | $44.9M | 1.29% | +1.41% | |
| 21 | ARK Investment ManagementARK | $44.8M | 1.29% | −0.13% | |
| 22 | Delaware Management HoldingsDelaware | $40.5M | 1.16% | +0.43% | |
| 23 | Aristotle Atlantic PartnersAristotle Atlantic Partners | $39.4M | 1.13% | +7.24% | |
| 24 | Toronto Dominion BankToronto Dominion Bank | $38.6M | 1.11% | new | |
| 25 | T. Rowe Price Investment ManagementT. Rowe Price | $38.2M | 1.09% | +93.59% |
299 managers report $3.5B of Adaptive Biotechnologies on form 13F for the quarter ended Jun 30 '26. 36 of them hold 80% of it; Viking Global Investors is largest at 18.45%.
Expected move
Inputs8Q avg ±10.8%·×1.74·rich
straddle ±18.8%
spot 26.64exp Nov 20ATM strike 25ATM straddle 5.90IV 117%